Unbiased AI-powered news
4 stories related to this topic, newest first.
ForbesUniversal Brain received FDA 510(k) clearance for its Neurotique platform, a five-minute EEG-based test for cognitive and emotional brain function. The company plans to launch the device this summer with 250 clinics and pursue pharma contracts.
cnet.comUpDoc received FDA clearance in December for its diabetes management app and announced the approval in late June. The app uses an LLM-based chatbot interface to deliver doctor-defined treatment instructions.
forbes.comAnalysts expect NRx Pharmaceuticals to post a loss of 11 cents per share on $19.43 million in revenue. The company recently received FDA clearance to begin a clinical trial of NRX-101. Several analysts maintained Buy ratings with price targets ranging from $25 to $49.
BenzingaElutia released first-quarter results on May 14, 2026, showing improved gross margin and progress on its automated manufacturing platform. The company anticipates FDA clearance for its NXT41 product in Q4 2026. CEO Randy Mills highlighted the $1.5 billion U.S. breast reconstructi…